94 related articles for article (PubMed ID: 8734896)
1. Evaluation of cardiorespiratory parameters in rats after spinal cord trauma and treatment with NBQX, an antagonist of excitatory amino acid receptors.
Teng YD; Wrathall JR
Neurosci Lett; 1996 May; 209(1):5-8. PubMed ID: 8734896
[TBL] [Abstract][Full Text] [Related]
2. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
Wrathall JR; Teng YD; Choiniere D
Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX.
Wrathall JR; Choiniere D; Teng YD
J Neurosci; 1994 Nov; 14(11 Pt 1):6598-607. PubMed ID: 7965063
[TBL] [Abstract][Full Text] [Related]
5. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline (NBQX) increases fibroblast growth factor mRNA levels after contusive spinal cord injury.
Follesa P; Wrathall JR; Mocchetti I
Brain Res; 1998 Jan; 782(1-2):306-9. PubMed ID: 9519278
[TBL] [Abstract][Full Text] [Related]
6. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion.
Rosenberg LJ; Teng YD; Wrathall JR
J Neurosci; 1999 Jan; 19(1):464-75. PubMed ID: 9870974
[TBL] [Abstract][Full Text] [Related]
7. Altered glutamate receptor function during recovery of bladder detrusor-external urethral sphincter coordination in a rat model of spinal cord injury.
Pikov V; Wrathall JR
J Pharmacol Exp Ther; 2002 Feb; 300(2):421-7. PubMed ID: 11805200
[TBL] [Abstract][Full Text] [Related]
8. Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest.
Brambrink AM; Martin LJ; Hanley DF; Becker KJ; Koehler RC; Traystman RJ
J Cereb Blood Flow Metab; 1999 Aug; 19(8):927-38. PubMed ID: 10458600
[TBL] [Abstract][Full Text] [Related]
9. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo.
Sato K; Morimoto K; Yamada N; Kuroda S; Hayabara T
Brain Res; 1995 Jun; 683(2):279-82. PubMed ID: 7552367
[TBL] [Abstract][Full Text] [Related]
10. Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury.
Wrathall JR; Teng YD; Choiniere D; Mundt DJ
Brain Res; 1992 Jul; 586(1):140-3. PubMed ID: 1324778
[TBL] [Abstract][Full Text] [Related]
11. Effect of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline on methamphetamine- and cocaine-induced behavioral sensitization.
Akiyama K; Ujike H; Sakai K; Shimizu Y; Kodama M; Kuroda S
Pharmacol Biochem Behav; 1998 Dec; 61(4):419-26. PubMed ID: 9802837
[TBL] [Abstract][Full Text] [Related]
12. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
Randle JC; Guet T; Cordi A; Lepagnol JM
Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998
[TBL] [Abstract][Full Text] [Related]
13. Participation of NMDA and non-NMDA excitatory amino acid receptors in the mediation of spinal reflex potentials in rats: an in vivo study.
Farkas S; Ono H
Br J Pharmacol; 1995 Mar; 114(6):1193-205. PubMed ID: 7620709
[TBL] [Abstract][Full Text] [Related]
14. Role of spinal NMDA and AMPA receptors in episodic hypertension in conscious spinal rats.
Maiorov DN; Krenz NR; Krassioukov AV; Weaver LC
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1266-74. PubMed ID: 9321815
[TBL] [Abstract][Full Text] [Related]
15. Sympathoexcitation by PVN-injected bicuculline requires activation of excitatory amino acid receptors.
Chen QH; Haywood JR; Toney GM
Hypertension; 2003 Oct; 42(4):725-31. PubMed ID: 12900439
[TBL] [Abstract][Full Text] [Related]
16. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
von Euler M; Seiger A; Holmberg L; Sundström E
Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838
[TBL] [Abstract][Full Text] [Related]
17. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
18. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine.
Li Y; Vartanian AJ; White FJ; Xue CJ; Wolf ME
Psychopharmacology (Berl); 1997 Dec; 134(3):266-76. PubMed ID: 9438676
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
Swedberg MD; Jacobsen P; Honoré T
J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.
Zeman S; Lodge D
Br J Pharmacol; 1992 Jun; 106(2):367-72. PubMed ID: 1382781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]